Alexis Bujold

1.3k total citations · 1 hit paper
13 papers, 800 citations indexed

About

Alexis Bujold is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Hepatology. According to data from OpenAlex, Alexis Bujold has authored 13 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 6 papers in Hepatology. Recurrent topics in Alexis Bujold's work include Advanced Radiotherapy Techniques (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Alexis Bujold is often cited by papers focused on Advanced Radiotherapy Techniques (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Alexis Bujold collaborates with scholars based in Canada and Saudi Arabia. Alexis Bujold's co-authors include Laura A. Dawson, James D. Brierley, Jolie Ringash, Zahra Kassam, John J. Kim, Christine Massey, Charles Cho, Rebecca Wong, Bernard Cummings and Jenna Sykes and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Alexis Bujold

12 papers receiving 790 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

2013 572 citations Alexis Bujold, Christine Massey et al. Journal of Clinical Oncology profile →

Peers

Alexis Bujold

HEPAT

RADIA

PRM

SURGE

RNMI

Sun Hyun Bae South Korea

David L. Andolino United States

Yuichiro Tsurugai Japan

R. Dinniwell Canada

Young Nam Kang South Korea

Jian-Kuen Wu Taiwan

Wouter Wunderink Netherlands

Yousuke Aoki Japan

Qiao-Qiao Li China

Yohei Oku Japan

Sun Hyun Bae South Korea

Alexis Bujold

619 ×1.2

HEPAT

364 ×1.0

RADIA

309 ×1.0

PRM

277 ×1.2

SURGE

177 ×0.8

RNMI

Citations per year, relative to Alexis Bujold Alexis Bujold (= 1×) peers Sun Hyun Bae

Countries citing papers authored by Alexis Bujold

Since Specialization

Citations

This map shows the geographic impact of Alexis Bujold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis Bujold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis Bujold more than expected).

Fields of papers citing papers by Alexis Bujold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis Bujold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis Bujold. The network helps show where Alexis Bujold may publish in the future.

Co-authorship network of co-authors of Alexis Bujold

This figure shows the co-authorship network connecting the top 25 collaborators of Alexis Bujold. A scholar is included among the top collaborators of Alexis Bujold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexis Bujold. Alexis Bujold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Wierzbicki, Marcin, Sameer Parpia, Vijayananda Kundapur, et al.. (2024). Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial. Radiotherapy and Oncology. 202. 110605–110605.

2.

Swaminath, Anand, Sameer Parpia, Marcin Wierzbicki, et al.. (2022). LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology*Biology*Physics. 114(5). 1061–1062. 4 indexed citations

3.

Fortin, B., et al.. (2021). Frameless Stereotactic Radiosurgery With Linear Accelerator (LINAC)-Based Technology for Brain Metastases: Outcomes Analysis in 141 Patients. Cureus. 13(6). e15475–e15475. 1 indexed citations

4.

Garant, Aurélie, Slobodan Dević, André‐Guy Martin, et al.. (2019). Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(5). 1005–1011. 29 indexed citations

5.

Fortin, B., Nader Khaouam, Édith Filion, et al.. (2016). Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics. 95(2). 647–653. 22 indexed citations

6.

Campeau, Marie‐Pierre, David Roberge, David Donath, et al.. (2016). Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience. Cureus. 8(12). e935–e935. 11 indexed citations

7.

Bujold, Alexis, Christine Massey, John J. Kim, et al.. (2013). Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma. Journal of Clinical Oncology. 31(13). 1631–1639. 572 indexed citations breakdown →

8.

Dawson, Laura A., Sameh Hashem, & Alexis Bujold. (2012). Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book. 261–264. 10 indexed citations

9.

Bujold, Alexis & Laura A. Dawson. (2011). Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma. Cancer/Radiothérapie. 15(1). 54–63. 32 indexed citations

10.

Bujold, Alexis, Tim Craig, David A. Jaffray, & Laura A. Dawson. (2011). Image-Guided Radiotherapy: Has It Influenced Patient Outcomes?. Seminars in Radiation Oncology. 22(1). 50–61. 111 indexed citations

11.

Bujold, Alexis, Zahra Kassam, R. Dinniwell, et al.. (2011). Outcomes following sequential trials of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 29(15_suppl). 4111–4111. 3 indexed citations

12.

Bujold, Alexis, et al.. (2011). Outcomes of Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC). International Journal of Radiation Oncology*Biology*Physics. 81(2). S70–S71. 2 indexed citations

13.

Bujold, Alexis, et al.. (2006). Can intraoperative inverse planning predict rectal dose in permanent seed implants of the prostate?. Brachytherapy. 5(2). 106–106. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact